$中国中药 (00570.HK)没有私有化建议之前的都还有 3.4 左右,这个消息和它本身估值存在偏差

The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.